Literature DB >> 18946350

"Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males.

Luis E Morales-Buenrostro1, Paul I Terasaki, Lluvia A Marino-Vázquez, Jar-How Lee, Nadim El-Awar, Josefina Alberú.   

Abstract

BACKGROUND: Human leukocyte antigen (HLA) antibodies were normally not found in subjects who have not been immunized by pregnancies, transfusions, or transplants. But with new methodology, we now see that HLA antibodies are often found in nonalloimmunized males.
METHODS: The sera of 424 healthy male donors were tested with single antigen Luminex beads.
RESULTS: Human leukocyte antigen antibodies were detected in 63% of 424 male blood donors when a fluorescent value of more than 1000 was used as the cutoff. Antibodies to class I was found in 42%, class II in 11% and both in 12%. Five males who were tested eight times over a 6-month period consistently had the same specificity at similar strength levels at each testing. The antibodies reacted with specificities that are rare in the general population: 18.9% had antibodies to A*3002; more than 10% had antibodies to A*3101, B76, B*8201, and Cw*1701. About half of the donors with antibodies had one or two specificities; the other half had three or more specificities. Among those with class II specificities, 20.5% had antibodies to DPA1*0201/DPB1*0101, and 10.8% to DQA1*0503/DQB1*0301. Because the above data were obtained by testing sera of 424 Mexican donors, as a check, 29 males in Los Angeles were tested and shown to have similar specificities at roughly similar frequencies.
CONCLUSIONS: Normal males were found to have HLA antibodies to infrequent HLA specificities. It is likely that these HLA antibodies are produced to cross-reactive epitopes found in microorganisms, ingested proteins and allergens-making them natural antibodies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18946350     DOI: 10.1097/TP.0b013e318186d87b

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  60 in total

1.  Post-transplantation-emerging anti-HLA DQA1/DQB1 antibody possibly responsible for graft rejection after myeloablative-unrelated marrow grafting.

Authors:  H Yabe; T Morimoto; H Takakura; M Okuya; R Ikegaya; S Kato; T Sugimoto; F Tsuchida; M Murakami; H Mochizuki; M Yabe
Journal:  Bone Marrow Transplant       Date:  2015-12-07       Impact factor: 5.483

Review 2.  Sensitive solid-phase detection of donor-specific antibodies as an aid highly relevant to improving allograft outcomes.

Authors:  Gerald Schlaf; Beatrix Pollok-Kopp; Wolfgang W Altermann
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

3.  The 'HLA conundrum in bone marrow transplantation': correct interpretation of anti-HLA antibodies in haploidentical donor selection.

Authors:  A L Dias; S Hashmi; W Hogan; N Baig; L Wakefield; J Kreuter; M J Gandhi
Journal:  Bone Marrow Transplant       Date:  2017-02-20       Impact factor: 5.483

4.  Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation.

Authors:  Corey Cutler; Haesook T Kim; Lixian Sun; Doreen Sese; Brett Glotzbecker; Philippe Armand; John Koreth; Vincent Ho; Edwin Alyea; Karen Ballen; Jerome Ritz; Robert J Soiffer; Edgar Milford; Joseph H Antin
Journal:  Blood       Date:  2011-09-22       Impact factor: 22.113

5.  Conformational Variants of the Individual HLA-I Antigens on Luminex Single Antigen Beads Used in Monitoring HLA Antibodies: Problems and Solutions.

Authors:  Vadim Jucaud; Mepur H Ravindranath; Paul I Terasaki
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

6.  Washing red cells after leucodepletion does not decrease human leukocyte antigen sensitization risk in patients with chronic kidney disease.

Authors:  Antony Aston; Rebecca Cardigan; Saber Bashir; Susan Proffitt; Helen New; Colin Brown; Ri Liesner; Sylvia Hennem; Helen Nulty; Olivia Shaw; Robert Vaughan; Jon Jin Kim; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2014-04-29       Impact factor: 3.714

7.  Absence of donor-specific anti-HLA antibodies after ABO-incompatible heart transplantation in infancy: altered immunity or age?

Authors:  S Urschel; P M Campbell; S R Meyer; I M Larsen; J Nuebel; J Birnbaum; H Netz; K Tinckam; T Kauke; K Derkatz; J Y Coe; J L Platt; L J West
Journal:  Am J Transplant       Date:  2009-11-24       Impact factor: 8.086

8.  Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI) and Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) analysis.

Authors:  Annalisa Ruggeri; Vanderson Rocha; Emeline Masson; Myriam Labopin; Renato Cunha; Lena Absi; Ali Boudifa; Brigitte Coeffic; Anne Devys; Muriel De Matteis; Valérie Dubois; Daniel Hanau; Françoise Hau; Isabelle Jollet; Dominique Masson; Beatrice Pedron; Pascale Perrier; Christophe Picard; Annie Ramouneau-Pigot; Fernanda Volt; Dominique Charron; Eliane Gluckman; Pascale Loiseau
Journal:  Haematologica       Date:  2012-12-14       Impact factor: 9.941

9.  Evidence to Support a Contribution of Polyreactive Antibodies to HLA Serum Reactivity.

Authors:  Baoshan Gao; Chunshu Rong; Fabrice Porcheray; Carolina Moore; Timothy C Girouard; Susan L Saidman; Waichi Wong; Yaowen Fu; Emmanuel Zorn
Journal:  Transplantation       Date:  2016-01       Impact factor: 4.939

10.  Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors.

Authors:  Ram M Kakaiya; Darrell J Triulzi; David J Wright; Whitney R Steele; Steven H Kleinman; Michael P Busch; Philip J Norris; Christopher D Hillyer; Jerome L Gottschall; Jorge A Rios; Patricia Carey; Simone A Glynn
Journal:  Transfusion       Date:  2010-01-08       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.